Cerebrospinal Fluid (CSF) biomarkers can also be useful in the prediction of PD-CD, one study [34] demonstrated the possible involvement of tau species in the progression of cognitive symptoms in PD. This evidence concerns the gene MAPT and Parkinson disease.